Accelerating Cortical Thinning: Unique to Dementia or Universal in Aging?
Authors:
- Anders M. FjellAFAnders M. Fjell
- Lars T. WestlyeLWLars T. Westlye
- Håkon GrydelandHGHåkon Grydeland
- Inge AmlienIAInge Amlien
- For The Alzheimer Disease Neuroimaging InitiativeFIFor The Alzheimer Disease Neuroimaging Initiative
Open Access
- 12 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 24 (4) , 919-934
Abstract
Does accelerated cortical atrophy in aging, especially in areas vulnerable to early Alzheimer's disease (AD), unequivocally signify neurodegenerative disease or can it be part of normal aging? We addressed this in 3 ways. First, age trajectories of cortical thickness were delineated cross-sectionally (n = 1100) and longitudinally (n = 207). Second, effects of undetected AD on the age trajectories were simulated by mixing the sample with a sample of patients with very mild to moderate AD. Third, atrophy in AD-vulnerable regions was examined in older adults with very low probability of incipient AD based on 2-year neuropsychological stability, CSF Aβ1-42 levels, and apolipoprotein ɛ4 negativity. Steady decline was seen in most regions, but accelerated cortical thinning in entorhinal cortex was observed across groups. Very low-risk older adults had longitudinal entorhinal atrophy rates similar to other healthy older adults, and this atrophy was predictive of memory change. While steady decline in cortical thickness is the norm in aging, acceleration in AD-prone regions does not uniquely signify neurodegenerative illness but can be part of healthy aging. The relationship between the entorhinal changes and changes in memory performance suggests that non-AD mechanisms in AD-prone areas may still be causative for cognitive reductions.Keywords
This publication has 105 references indexed in Scilit:
- Nonlinear registration of longitudinal images and measurement of change in regions of interestMedical Image Analysis, 2011
- Age-related gray matter volume changes in the brain during non-elderly adulthoodNeurobiology of Aging, 2011
- Amyloid‐β associated cortical thinning in clinically normal elderlyAnnals of Neurology, 2010
- Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI studyNeurobiology of Aging, 2010
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound BArchives of Neurology, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- “When does age-related cognitive decline begin?” Salthouse again reifies the “cross-sectional fallacy”Neurobiology of Aging, 2009
- When does age-related cognitive decline begin?Neurobiology of Aging, 2009
- Structural MRI biomarkers for preclinical and mild Alzheimer's diseaseHuman Brain Mapping, 2009
- Cortical Surface-Based AnalysisNeuroImage, 1999